Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Brucella suis histidinol dehydrogenase: synthesis and inhibition studies of substituted N-L-histidinylphenylsulfonyl hydrazide.

Abdo MR, Joseph P, Boigegrain RA, Montero JL, Köhler S, Winum JY.

J Enzyme Inhib Med Chem. 2008 Jun;23(3):357-61. doi: 10.1080/14756360701617107 .

PMID:
18569340
2.

Targeting of the Brucella suis virulence factor histidinol dehydrogenase by histidinol analogues results in inhibition of intramacrophagic multiplication of the pathogen.

Joseph P, Abdo MR, Boigegrain RA, Montero JL, Winum JY, Köhler S.

Antimicrob Agents Chemother. 2007 Oct;51(10):3752-5. Epub 2007 Aug 13.

3.

Brucella suis histidinol dehydrogenase: synthesis and inhibition studies of a series of substituted benzylic ketones derived from histidine.

Abdo MR, Joseph P, Boigegrain RA, Liautard JP, Montero JL, Köhler S, Winum JY.

Bioorg Med Chem. 2007 Jul 1;15(13):4427-33. Epub 2007 Apr 24.

PMID:
17481905
4.

The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB.

Dozot M, Boigegrain RA, Delrue RM, Hallez R, Ouahrani-Bettache S, Danese I, Letesson JJ, De Bolle X, Köhler S.

Cell Microbiol. 2006 Nov;8(11):1791-802. Epub 2006 Jun 27.

PMID:
16803581
5.

Antimicrobials: targeting virulence genes necessary for intracellular multiplication.

Liautard JP, Jubier-Maurin V, Boigegrain RA, Köhler S.

Trends Microbiol. 2006 Mar;14(3):109-13. Epub 2006 Feb 15.

PMID:
16469497
6.
7.

Release of periplasmic proteins of Brucella suis upon acidic shock involves the outer membrane protein Omp25.

Boigegrain RA, Salhi I, Alvarez-Martinez MT, Machold J, Fedon Y, Arpagaus M, Weise C, Rittig M, Rouot B.

Infect Immun. 2004 Oct;72(10):5693-703.

8.

Characterization of new members of the group 3 outer membrane protein family of Brucella spp.

Salhi I, Boigegrain RA, Machold J, Weise C, Cloeckaert A, Rouot B.

Infect Immun. 2003 Aug;71(8):4326-32.

9.

Production of the type IV secretion system differs among Brucella species as revealed with VirB5- and VirB8-specific antisera.

Rouot B, Alvarez-Martinez MT, Marius C, Menanteau P, Guilloteau L, Boigegrain RA, Zumbihl R, O'Callaghan D, Domke N, Baron C.

Infect Immun. 2003 Mar;71(3):1075-82.

10.

Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages.

Jubier-Maurin V, Boigegrain RA, Cloeckaert A, Gross A, Alvarez-Martinez MT, Terraza A, Liautard J, Köhler S, Rouot B, Dornand J, Liautard JP.

Infect Immun. 2001 Aug;69(8):4823-30.

11.

Low molecular weight serine protease inhibitors from insects are proteins with highly conserved sequences.

Boigegrain RA, Pugnière M, Paroutaud P, Castro B, Brehélin M.

Insect Biochem Mol Biol. 2000 Feb;30(2):145-52.

PMID:
10696590
12.

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.

Bignon E, Alonso R, Arnone M, Boigegrain R, Brodin R, Gueudet C, Héaulme M, Keane P, Landi M, Molimard JC, Olliero D, Poncelet M, Seban E, Simiand J, Soubrié P, Pascal M, Maffrand JP, Le Fur G.

J Pharmacol Exp Ther. 1999 May;289(2):752-61.

PMID:
10215649
13.

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.

Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert JM, Keane P, Labie C, Molimard JC, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh MP, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand JP, Le Fur G.

J Pharmacol Exp Ther. 1999 May;289(2):742-51.

PMID:
10215648
14.

X-ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist.

Quéré L, Longfils G, Boigegrain R, Labeeuw B, Gully D, Durant F.

Bioorg Med Chem Lett. 1998 Mar 17;8(6):653-8.

PMID:
9871577
15.

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.

Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, Steinberg R, Suaud-Chagny MF, Santucci V, Vita N, Pecceu F, Labbé-Jullié C, Kitabgi P, Soubrié P, Le Fur G, Maffrand JP.

J Pharmacol Exp Ther. 1997 Feb;280(2):802-12.

PMID:
9023294
16.

Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists.

Azzi M, Gully D, Heaulme M, Bérod A, Pélaprat D, Kitabgi P, Boigegrain R, Maffrand JP, LeFur G, Rostène W.

Eur J Pharmacol. 1994 Apr 1;255(1-3):167-74.

PMID:
8026542
17.

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A, et al.

Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):65-9.

18.

SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.

Kan JP, Steinberg R, Oury-Donat F, Michaud JC, Thurneyssen O, Terranova JP, Gueudet C, Souilhac J, Brodin R, Boigegrain R, et al.

Psychopharmacology (Berl). 1993;112(2-3):219-27.

PMID:
7871023
19.

Insect immunity: two proteinase inhibitors from hemolymph of Locusta migratoria.

Boigegrain RA, Mattras H, Brehélin M, Paroutaud P, Coletti-Previero MA.

Biochem Biophys Res Commun. 1992 Dec 15;189(2):790-3.

PMID:
1472051
20.

Purification of a protease inhibitor which controls prophenoloxidase activation in hemolymph of Locusta migratoria (insecta).

Brehélin M, Boigegrain RA, Drif L, Coletti-Previero MA.

Biochem Biophys Res Commun. 1991 Sep 16;179(2):841-6.

PMID:
1910340
21.

Molecular recognition between serine proteases and new bioactive microproteins with a knotted structure.

Le Nguyen D, Heitz A, Chiche L, Castro B, Boigegrain RA, Favel A, Coletti-Previero MA.

Biochimie. 1990 Jun-Jul;72(6-7):431-5.

PMID:
2124146
22.

N-terminal domain of pepsin as a model for retroviral dimeric aspartyl protease.

Bianchi M, Boigegrain RA, Castro B, Coletti-Previero MA.

Biochem Biophys Res Commun. 1990 Feb 28;167(1):339-44.

PMID:
2106884
23.

Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents.

Croci T, Cecchi R, Tarantino A, Aureggi G, Bianchetti A, Boigegrain R, Manara L.

Pharmacol Res Commun. 1988 Feb;20(2):147-51.

PMID:
2898155
24.

N-nitrosobutyl-N-(4-hydroxybutyl)amine glucuronide in vitro synthesis, characterization by mass spectrometry and determination by gas chromatography-thermal energy analysis.

Boigegrain RA, Bonfanti M, Fanelli R, Airoldi L.

J Chromatogr. 1986 Nov 28;383(1):172-8. No abstract available.

PMID:
3818835
25.

Radical activation of carbon tetrachloride in foetal and maternal rat liver microsomes.

Cambon-Gros C, Deltour P, Boigegrain RA, Fernandez Y, Mitjavila S.

Biochem Pharmacol. 1986 Jun 15;35(12):2041-4. No abstract available.

PMID:
3013208
26.

Na+-coupled D-glucose uptake and membrane order of enterocyte brush border membrane vesicles, under the effect of a series of N-phenylcarbamates.

Fernandez Y, Boigegrain RA, Cambon-Gros C, Deltour P, Mitjavila S.

FEBS Lett. 1986 May 26;201(1):119-23.

27.

[Nutritional status of the rat in refeeding following massive mobilization of DDT by fasting].

Carrera G, Boigegrain RA, Mitjavila S.

Ann Nutr Metab. 1985;29(1):56-62. French.

PMID:
3977295
28.

Thermodynamic interpretation of effects of alcohols on membrane lipid fluidity.

Boigegrain RA, Fernandez Y, Massol M, Mitjavila S.

Chem Phys Lipids. 1984 Oct;35(4):321-30.

PMID:
6094034
29.
30.

Hepatic microsomal calcium uptake during the perinatal period.

Cambon-Gros C, Boigegrain RA, Mitjavila S.

Dev Pharmacol Ther. 1984;7 Suppl 1:38-41. No abstract available.

PMID:
6518968
31.

[Deperoxidation of hydroperoxylinoleic acid by the intestinal mucosa].

Boigegrain RA, Derache P, Mitjavila S.

Food Chem Toxicol. 1983 Apr;21(2):181-5. French.

PMID:
6682080
32.

Kappa binding sites in guinea-pig brain membranes: evidence for a dynorphin-resistant subtype.

Morre M, Bachy A, Gout B, Boigegrain R, Arnone M, Roncucci R.

Life Sci. 1983;33 Suppl 1:179-82.

PMID:
6141484
33.

[Effect of preincubation of hepatic microsomes in the presence of chloramphenicol on microsomal lipid peroxidation].

Derache P, Boigegrain RA, Derache R.

C R Seances Acad Sci III. 1982 Jan 11;294(2):99-102. French.

PMID:
6805857
34.

Analgesia, new research approaches.

Morre M, Boigegrain R, Roncucci R.

Biomed Pharmacother. 1982;36(6-7):282-5.

PMID:
6763879
35.

Evaluation of the toxic risk of DDT in the rat: during accumulation.

Mitjavila S, Carrera G, Boigegrain RA, Derache R.

Arch Environ Contam Toxicol. 1981 Jul;10(4):459-69.

PMID:
7259308
36.

[Comparison of the effects of linoleic acid and linoleic acid hydroperoxide on the enzymatic activities of enterocytes isolated from the intestine of the rat].

Dinh CL, Boigegrain RA, Mitjavila S, Derache R.

Food Cosmet Toxicol. 1980 Apr;18(2):123-8. French. No abstract available.

PMID:
7390333

Supplemental Content

Loading ...
Support Center